The current valuation score of MiMedx Group Inc is 6.66, ranking 270 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 19.87, which is 68.33% below the recent high of 33.45 and 2216.73% above the recent low of -420.62.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.